These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2825548)

  • 1. Clinical correlates of platelet prostaglandin receptor subsensitivity in schizophrenia.
    Kanof PD; Davidson M; Johns CA; Mohs RC; Davis KL
    Am J Psychiatry; 1987 Dec; 144(12):1556-60. PubMed ID: 2825548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin receptor sensitivity in psychiatric disorders.
    Kanof PD; Johns C; Davidson M; Siever LJ; Coccaro EF; Davis KL
    Arch Gen Psychiatry; 1986 Oct; 43(10):987-93. PubMed ID: 3019269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet prostaglandin E1 hyposensitivity in schizophrenia: reduction of prostaglandin E1- or forskolin-stimulated cyclic AMP response in platelets.
    Ofuji M; Kaiya H; Nozaki M; Tsurumi K
    Life Sci; 1989; 45(22):2135-40. PubMed ID: 2557518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-adrenergic receptors and cyclic AMP production in a group of schizophrenic patients.
    Kafka MS; Kleinman JE; Karson CN; Wyatt RJ
    Hillside J Clin Psychiatry; 1986; 8(1):15-24. PubMed ID: 3017834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet alpha 2-adrenergic receptor function in psychiatric disorders.
    Kanof PD; Johns CA; Davidson M; Siever LJ; Coccaro EF; Davis KL
    Psychiatry Res; 1988 Jan; 23(1):11-22. PubMed ID: 2834762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding of 6-oxo-prostaglandin E1 to platelet prostanoid receptors.
    Jaschonek K; Renn W; Weisenberger H
    Prostaglandins Leukot Med; 1986 Sep; 24(1):79-86. PubMed ID: 3020591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migraine: possible role of platelet insensitivity to prostaglandin E1 (PGE1).
    Cerneca F; de Luyk S; Radillo O; Simeone R; Mangiarotti M
    Funct Neurol; 1993; 8(6):403-8. PubMed ID: 8150318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of insulin receptors in the expression of prostaglandin E1 binding activity in platelets.
    Kahn NN; Sinha AK
    Adv Exp Med Biol; 1990; 281():271-6. PubMed ID: 1966355
    [No Abstract]   [Full Text] [Related]  

  • 10. Impaired noradrenergic transmission in schizophrenia?
    van Kammen DP; Antelman S
    Life Sci; 1984 Apr; 34(15):1403-13. PubMed ID: 6323903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased platelet reactivity to prostaglandin E1 in hypertension is linked with altered signal transduction.
    Huzoor-Akbar ; Dean T; Kornhauser R
    Am J Hypertens; 1993 Oct; 6(10):857-62. PubMed ID: 7505593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet prostaglandin E1 hyposensitivity in schizophrenia: decrease in cyclic AMP formation and in inhibitory effects on aggregation.
    Kaiya H; Ofuji M; Nozaki M; Tsurumi K
    Psychopharmacol Bull; 1990; 26(3):381-4. PubMed ID: 2177206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PGE1 and PGE2 modify platelet function through different prostanoid receptors.
    Iyú D; Jüttner M; Glenn JR; White AE; Johnson AJ; Fox SC; Heptinstall S
    Prostaglandins Other Lipid Mediat; 2011 Feb; 94(1-2):9-16. PubMed ID: 21095237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia and reduced cyclic AMP production: evidence for the role of receptor-linked events.
    Garver DL; Johnson C; Kanter DR
    Life Sci; 1982 Nov; 31(18):1987-92. PubMed ID: 6294425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced cyclic AMP production in the blood platelets from schizophrenic patients.
    Kafka MS; van Kammen DP; Bunney WE
    Am J Psychiatry; 1979 May; 136(5):685-7. PubMed ID: 219720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients.
    Martinot JL; Peron-Magnan P; Huret JD; Mazoyer B; Baron JC; Boulenger JP; Loc'h C; Maziere B; Caillard V; Loo H
    Am J Psychiatry; 1990 Jan; 147(1):44-50. PubMed ID: 2293788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assaying the SCF platelets cyclic nucleotides of schizophrenics and analyzing its correlation with pathopschological factors].
    Kang WH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Oct; 23(5):266-8, 318. PubMed ID: 2178085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.
    Miller OV; Gorman RR
    J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of in vitro and in vivo exposure to insulin upon prostaglandin E1 stimulation of platelet adenylate cyclase activity in healthy subjects.
    Jap TS; Kwok CF; Wong MC; Chiang H
    Diabetes Res; 1994; 27(1):39-46. PubMed ID: 7648795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alpha-tocopherol on platelet membrane function in cystic fibrosis.
    Davis PB; Hubbard VS; Dieckman L; Boat TF; Stern RC; Doershuk CF
    J Lab Clin Med; 1984 Aug; 104(2):203-12. PubMed ID: 6086795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.